Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Int. braz. j. urol ; 43(1): 67-72, Jan.-Feb. 2017. tab, graf
Article Dans Anglais | LILACS | ID: biblio-840793

Résumé

ABSTRACT Objective Recent studies have demonstrated the role of systemic inflammation in the development and progression of cancer. In this study, we evaluated whether preoperatively measured neutrophil-to-lymphocyte ratio (NLR) can predict lamina propria invasion in patients with non-muscle-invasive bladder cancer (NMIBC). Material and Methods We reviewed the medical records of 304 consecutive and newly diagnosed patients with bladder cancer who had been treated with transurethral resection between January 2008 and June 2014. In total, 271 patients were included in the study and the patients were divided into two groups according to the pathological stage (Group 1: Ta, Group 2: T1). NLR was calculated by dividing the absolute neutrophil count (N) by the absolute lymphocyte count (L). Results In total, 271 patients (27 women and 244 men) were enrolled. Mean age was higher in Group 2 than in Group 1 (67.3±10.8 vs. 62.9±10.8, p<0.001). Furthermore, the presence of high grade tumors and tumors ≥3cm in size was statistically higher in Group 2 than in Group 1 (70.9% vs. 9.9%, p=0.0001; 71.8% vs. 36%, p=0.0001, respectively). While the mean white blood cell (WBC) and N counts were statistically insignificant (7.63±1.87 vs. 7.69±1.93, p=0.780; 4.72±1.54 vs. 4.46±1.38, p=0.140; respectively), L was significantly lower and NLR was significantly higher in Group 2 than in Group 1 (2.07±0.75 vs. 2.4±0.87, p=0.001; 2.62±1.5 vs. 2.19±1.62, p=0.029; respectively). Conclusion Our data indicate that high NLR and low L are statistically associated with T1 stage, whereas low L are able to predict lamina propria invasion in patients with NMIBC. These findings suggest that pretreatment measurement of NLR may provide valuable information for the clinical management of patients with NMIBC. Prospective studies are now required to further validate the role of NLR as a risk factor in NMIBC.


Sujets)
Humains , Mâle , Femelle , Sujet âgé , Tumeurs de la vessie urinaire/anatomopathologie , Tumeurs de la vessie urinaire/sang , Lymphocytes , Muqueuse/anatomopathologie , Granulocytes neutrophiles , Valeurs de référence , Marqueurs biologiques tumoraux/sang , Modèles logistiques , Dossiers médicaux , Reproductibilité des résultats , Études rétrospectives , Facteurs de risque , Sensibilité et spécificité , Numération des lymphocytes , Évolution de la maladie , Charge tumorale , Grading des tumeurs , Adulte d'âge moyen
2.
Int. braz. j. urol ; 42(3): 540-545, tab, graf
Article Dans Anglais | LILACS | ID: lil-785726

Résumé

ABSTRACT This prospective analysis assessed the effect of histological prostatitis on lower urinary tract functions and sexual function. The patients were separated into two groups as histologically observed prostatitis (Group A) and no prostatitis (Group B) according to the biopsy outcomes. International prostate symptom score, international index of erectile function-5 scores, maximal and average flow rate, and residual urine volumes were compared statistically between groups. There was no significant difference (P>0.05) in baseline age (t=0.64), body mass index value (t=0.51), prostate volume (t=0.87), prostate-specific antigen levels (t=0.43), maximal (t=0.84) and average flow rate (t=0.59), and post-void residual urine volume (t=0.71). Mean international prostate symptom score in patients with prostatitis was numerically but not significantly higher than that in those without prostatitis (t=0.794, P=0.066). Mean international index of erectile function-5 score in the prostatitis group was significantly lower than that in those without prostatitis (t=1.854, P=0.013). Histological prostatitis notably affected sexual function of patients and may serve as a major risk factor for sexual dysfunction while having little effect on lower urinary tract symptoms.


Sujets)
Humains , Mâle , Sujet âgé , Prostatite/physiopathologie , Prostatite/anatomopathologie , Symptômes de l'appareil urinaire inférieur/physiopathologie , Dysfonctionnement érectile/physiopathologie , Taille d'organe , Prostate/anatomopathologie , Hyperplasie de la prostate/physiopathologie , Hyperplasie de la prostate/anatomopathologie , Ponction-biopsie à l'aiguille , Indice de gravité de la maladie , Indice de masse corporelle , Maladie chronique , Analyse multifactorielle , Études prospectives , Antigène spécifique de la prostate/sang , Statistique non paramétrique , Évolution de la maladie , Symptômes de l'appareil urinaire inférieur/anatomopathologie , Dysfonctionnement érectile/anatomopathologie , Adulte d'âge moyen
SÉLECTION CITATIONS
Détails de la recherche